A Phase III, Randomized, Observer-Masked, Active-Controlled, Parallel-Group, Multinational and Multicenter Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution 0.002% Compared With Latanoprost Ophthalmic Solution 0.005% in Subjects With Open-Angle Glaucoma or Ocular Hypertension- PEONY Study
Phase: PHASE3
Conditions: Open Angle Glaucoma or Ocular Hypertension
Sponsor: Santen Pharmaceutical Co., Ltd.

 
 
Study Protocol Cover Page 
 
Official Study Title:  
A Phase III, Randomized, Observer-Masked, Active-Controlled, 
Parallel-Group, Multinational and Multicenter Study Assessing the 
Safety and Efficacy of DE-117 Ophthalmic Solution 0.002% 
Compared with Latanoprost Ophthalmic Solution 0.005% in 
Subjects with Open-Angle Glaucoma or Ocular Hypertension- 
PEONY Study 
 
 
NCT Number:  
NCT02981446
 
Date of the document:
 28 Jun 2016